PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2004 | 2 |
| 2008 | 6 |
| 2009 | 15 |
| 2010 | 15 |
| 2011 | 12 |
| 2012 | 10 |
| 2013 | 21 |
| 2014 | 17 |
| 2015 | 22 |
| 2016 | 25 |
| 2017 | 26 |
| 2018 | 26 |
| 2019 | 27 |
| 2020 | 39 |
| 2021 | 79 |
| 2022 | 63 |
| 2023 | 43 |
| 2024 | 57 |
| 2025 | 43 |
| 2026 | 27 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Prostate Cancer Prostatic Dis"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Feasibility and safety of single-port transvesical simple prostatectomy in patients with very large prostates: A volume-stratified analysis.
- Qi JC, Tang S, Wang DB, Fu ZL, Santodirocco L, Alkassis M, Sauer Calvo R, Qu CB, Wang YX, Crivellaro S.
- Prostate Cancer Prostatic Dis. 2026 May 28;29(4):854-861. doi: 10.1038/s41391-026-01121-8.
- PMCID: PMC13623653
Qi JC, et al.Prostate Cancer Prostatic Dis. 2026.PMCID: PMC13623653 -
Contrast-free MRI-first screening in young asymptomatic men: Prostate characteristics and cancer detection rates.
- Messina E, Laschena L, Borrelli A, Mezzapesa F, Lucciola S, Giuliani L, Giuliani P, Bicchetti M, Sciarra A, Panebianco V.
- Prostate Cancer Prostatic Dis. 2026 May 13;29(4):846-853. doi: 10.1038/s41391-026-01116-5.
- PMCID: PMC13623644
Messina E, et al.Prostate Cancer Prostatic Dis. 2026.PMCID: PMC13623644 -
Predictors of durability of the prostatic urethral lift (PUL) for benign prostatic hyperplasia.
- Eure G, Ashley M, Rukstalis DB, Chin P, Barber N, Roehrborn C.
- Prostate Cancer Prostatic Dis. 2026 May 6;29(4):836-839. doi: 10.1038/s41391-026-01101-y.
- PMCID: PMC13623641
Eure G, et al.Prostate Cancer Prostatic Dis. 2026.PMCID: PMC13623641 -
Response to correspondence regarding "The value of micro-ultrasound for prostate cancer screening: a retrospective real-world feasibility study".
- Wendler JJ, Bechstein J, Cash H.
- Prostate Cancer Prostatic Dis. 2026 Mar 26;29(4):909-910. doi: 10.1038/s41391-026-01112-9.
- PMCID: PMC13623652
Wendler JJ, et al.Prostate Cancer Prostatic Dis. 2026.PMCID: PMC13623652 -
Mitochondrial dysfunction in urologic disease.
- Adrian AE, Boucher NJ, McVary KT, DeFranco DB, Ricke WA.
- Prostate Cancer Prostatic Dis. 2026 Mar 24;29(4):728-734. doi: 10.1038/s41391-026-01097-5.
- PMCID: PMC13623628
Adrian AE, et al.Prostate Cancer Prostatic Dis. 2026.PMCID: PMC13623628 -
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.
- Bleve S, Ravera F, Rodrigues S, Pederzoli F, Pakula H, Brighi N, Giunta EF, Schepisi G, Virga A, Gurioli G, Burgio SL, Fanelli GN, Butler LM, Nanus DM, Swinnen JV, Nuzzo PV, Lolli C, De Giorgi U, Loda M.
- Prostate Cancer Prostatic Dis. 2026 Mar 13;29(4):826-835. doi: 10.1038/s41391-026-01100-z.
- PMCID: PMC13139911
Bleve S, et al.Prostate Cancer Prostatic Dis. 2026.PMCID: PMC13139911 -
Survival trend in metastatic prostate cancer two decades of real-world data on overall survival from Germany.
- Sondermann M, Stehr A, Hirtsiefer C, Menzel V, Buttmann-Schweiger N, Flemming PW, Kraywinkel K, Thomas C, Boehm K.
- Prostate Cancer Prostatic Dis. 2026 Feb 24;29(4):820-825. doi: 10.1038/s41391-026-01092-w.
- PMCID: PMC13623643
Sondermann M, et al.Prostate Cancer Prostatic Dis. 2026.PMCID: PMC13623643 -
Single-port transvesical enucleation of the prostate (STEP) for benign prostatic hyperplasia: a comparative analysis of patients with large (80-150cc) and very large (>150cc) prostate volumes.
- Younis SK, Soputro NA, Pedraza AM, Mikesell CD, Al-Bayati A, Rai S, Wang L, Bernardino RM, Olivares R, Eltemamy M, Schwen ZR, Autorino R, Kaouk J.
- Prostate Cancer Prostatic Dis. 2026 Feb 21;29(4):791-798. doi: 10.1038/s41391-026-01074-y.
- PMCID: PMC13623656
Younis SK, et al.Prostate Cancer Prostatic Dis. 2026.PMCID: PMC13623656 -
Telesurgery in prostate cancer: a systematic review of clinical applications and future directions.
- Aksakal B, Soputro NA, Al-Bayati A, Secin M, Autorino R, Kaouk J, Olivares R.
- Prostate Cancer Prostatic Dis. 2026 Feb 20;29(4):709-716. doi: 10.1038/s41391-026-01090-y.
- PMCID: PMC13623627
Aksakal B, et al.Prostate Cancer Prostatic Dis. 2026.PMCID: PMC13623627 -
Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancer.
- Morgans AK, Wallis CJD, Halabi S, Armstrong AJ, Adorjan P, Ghadessi M, Verholen F, Grimm MO.
- Prostate Cancer Prostatic Dis. 2026 Feb 12;29(4):806-812. doi: 10.1038/s41391-026-01076-w.
- PMCID: PMC13623639
Morgans AK, et al.Prostate Cancer Prostatic Dis. 2026.PMCID: PMC13623639